7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
      
    		                 
      cash flows from operating activities
    		                 
      net income
    		-24,313,000 -33,858,000 -23,508,000 -20,216,000 -28,059,000 -5,959,000 -14,760,000 -11,758,000 -11,568,000 -17,508,000 -17,459,000 -16,065,000 -16,696,000 -16,888,000 -13,410,000 -13,416,000 -10,766,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                 
      depreciation
    		501,000 541,000 519,000 512,000 510,000 506,000 532,000 531,000 500,000 471,000 453,000 403,000 249,000 108,000 81,000 64,000 27,000 
      stock-based compensation
    		9,044,000 10,960,000 10,702,000 6,251,000 15,387,000 5,757,000 5,625,000 4,483,000 4,548,000 5,501,000 5,473,000 4,205,000 4,596,000 4,444,000 3,958,000 2,944,000 2,566,000 
      accretion of discounts on investments
    		-4,623,000 -5,206,000 -4,221,000 -2,927,000 -2,898,000 -2,973,000 -1,787,000 -2,061,000 -2,108,000 -1,841,000 -1,678,000       
      changes in operating assets and liabilities:
    		                 
      prepaid expenses and other current assets
    		449,000 -349,000 -700,000 -203,000 -144,000 -1,762,000 -1,171,000 270,000 530,000 -2,239,000 1,649,000 -81,000 -1,301,000 -587,000 -1,400,000 27,000 -43,000 
      other long-term assets
    		66,000 99,000 92,000 -61,000 -183,000 -116,000 -15,000 -195,000 119,000 -822,000 -221,000 -313,000 -1,142,000 130,000 55,000 -252,000  
      accounts payable
    		-168,000 1,113,000 -1,637,000 1,559,000 1,175,000 -694,000 -456,000 327,000 228,000 -171,000 -107,000 223,000 -634,000 857,000 -740,000 -482,000 2,584,000 
      accrued expenses
    		6,179,000 2,893,000 1,734,000 -1,634,000 4,573,000 3,060,000 -1,573,000 426,000 -1,987,000 1,443,000 -560,000 1,005,000 2,887,000 -894,000 1,158,000 1,921,000 409,000 
      deferred revenue
    		   0 -94,000 -878,000 -733,000 -1,943,000 -1,999,000 -682,000 -1,298,000 -2,095,000 -938,000 6,011,000 -1,214,000 -1,241,000 -784,000 
      operating lease right-of-use assets and liabilities
    		9,000 -6,000 -5,000 -6,000 2,000 19,000 20,000 19,000 28,000 44,000 587,000 1,597,000 833,000 845,000 14,000 12,000  
      net cash from operating activities
    		-12,856,000 -23,813,000 -17,024,000 -16,725,000 -2,231,000 -10,021,000 -14,837,000 -9,901,000 -11,709,000 -15,054,000 -13,911,000 -11,913,000 -13,414,000 -6,073,000 -11,522,000 -10,481,000 -5,854,000 
      capex
    		-93,000 -473,000 -371,000 -42,000 -25,000 -95,000 -197,000 -515,000 -470,000 -580,000 -285,000 -2,056,000 -2,520,000 -898,000 -971,000 -1,173,000 -77,000 
      free cash flows
    		-12,949,000 -24,286,000 -17,395,000 -16,767,000 -2,256,000 -10,116,000 -15,034,000 -10,416,000 -12,179,000 -15,634,000 -14,196,000 -13,969,000 -15,934,000 -6,971,000 -12,493,000 -11,654,000 -5,931,000 
      cash flows from investing activities
    		                 
      purchases of property and equipment
    		-93,000 -473,000 -371,000 -42,000 -25,000 -95,000 -197,000 -515,000 -470,000 -580,000 -285,000 -2,056,000 -2,520,000 -898,000 -971,000 -1,173,000 -77,000 
      purchases of short-term investments
    		-117,969,000 -92,685,000 -371,291,000 -24,032,000 -32,466,000 -235,540,000 -178,539,000 -33,112,000 -135,981,000 -76,546,000 -71,705,000 -86,048,000 -94,467,000 -68,813,000 -45,061,000 -103,501,000 -227,607,000 
      maturities of short-term investments
    		126,368,000 94,720,000 31,270,000 58,000,000 45,165,000 44,750,000 65,000,000 44,750,000 75,000,000 95,000,000 63,250,000 86,500,000 116,750,000 78,750,000 77,100,000 112,000,000  
      net cash from investing activities
    		8,306,000 1,562,000 -340,392,000 33,926,000 12,674,000 -190,885,000 -113,736,000 11,123,000 -61,451,000 17,874,000 -8,740,000 -1,604,000 19,763,000 9,039,000 31,068,000 7,326,000 -205,539,000 
      cash flows from financing activities
    		                 
      proceeds from exercise of common stock options and employee stock purchase plan
    		493,000   8,442,000 1,649,000   831,000          
      proceeds from the issuance of common stock and pre-funded common stock warrants, net of issuance costs
    		0 0 -347,000 378,208,000 0 -455,000 320,514,000 0          
      net cash from financing activities
    		493,000 954,000 554,000 386,650,000 1,649,000 2,765,000 322,171,000 831,000 56,609,000 528,000 1,580,000 191,000 0 308,000 1,000 164,000 -843,000 
      net increase in cash, cash equivalents and restricted cash
    		  -356,862,000 403,851,000   193,598,000 2,053,000 -16,551,000 3,348,000 -21,071,000 -13,326,000 6,349,000 3,274,000 19,547,000   
      cash, cash equivalents and restricted cash – beginning of year
    		0 0 431,421,000 0 0 0 20,021,000 0 0 0 52,242,000 0 0 0 36,398,000   
      cash, cash equivalents and restricted cash – end of period
    		-4,057,000 -21,297,000 74,559,000 403,851,000 12,092,000 -198,141,000 213,619,000 2,053,000 -16,551,000 3,348,000 31,171,000       
      supplemental disclosure of noncash investing and financing activities
    		                 
      unpaid property and equipment
    		54,000 -190,000 237,000 -36,000    -298,000 -30,000 65,000 395,000 -1,080,000 726,000     
      unrealized gain on available-for-sale securities
    		815,000 -9,000 1,593,000 -5,668,000 9,447,000 -1,092,000 -1,189,000 1,840,000 -115,000 -321,000 796,000  -370,000     
      operating lease liabilities arising from right-of-use assets
    		           344,000 0   0  
      accounts receivable
    		     -6,981,000 -519,000    -750,000     0 375,000 
      net decrease in cash, cash equivalents and restricted cash
    		                 
      proceeds from exercise of common stock options
    		  901,000    1,657,000           
      unpaid issuance costs
    		                 
      vesting of restricted common stock
    		   7,000 3,000 5,000 5,000 5,000 5,000 5,000 134,000 154,000 169,000 208,000 503,000 149,000 148,000 
      unpaid equity issuance costs
    		      438,000          -843,000 
      proceeds from exercise of vested and unvested common stock options and employee stock purchase plan
    		         528,000 1,580,000 191,000 0 308,000 1,000   
      loss on disposal of assets
    		               0 0 
      amortization (accretion) of premiums/discounts on investments
    		           -1,292,000 -768,000 -99,000 -24,000 -58,000 -79,000 
      proceeds from issuance of series a convertible preferred stock, net of issuance costs
    		               0 0 
      proceeds from issuance of series b convertible preferred stock, net of issuance costs
    		               0 0 
      proceeds from initial public offering, net of issuance costs
    		               0 -843,000 
      cash, cash equivalents and restricted cash – end of year
    		             3,274,000 55,945,000   
      conversion of convertible preferred stock in connection with initial public offering
    		               0 0 
      unrealized loss on available-for-sale securities
    		                 
      payment of initial public offering costs
    		                 
      unpaid fixed asset additions
    		              396,000 -815,000  
      unrealized loss on short-term investments
    		              -1,297,000   
      noncash interest – related parties
    		                 
      increase in fair value of convertible promissory notes – related parties
    		                 
      proceeds from issuance of convertible promissory notes
    		                 
      proceeds from issuance of series seed 2 convertible preferred stock, net of issuance costs
    		                 
      conversion of convertible promissory notes and accrued interest into shares of convertible preferred stock
    		                 
      unrealized gain on short-term investments
    		               -294,000 7,000 
      proceeds from exercise of vested and unvested common stock options
    		                0 
      net increase in cash and cash equivalents
    		                -212,236,000 
      cash and cash equivalents – beginning of period
    		                0 
      cash and cash equivalents – end of period
    		                -212,236,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.